TissueLabs
PrivateLast Round
Pre Seed
Mar 22, 2024
Total Funding Raised
$2.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
TissueLabs is a biotechnology company that provides a platform for creating tissues and organs in the lab, offering 3D bioprinters, tissue-specific biomaterials, and services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, 3D Printing, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TissueLabs Comparables
Compare TissueLabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 3D Biotechnology Solutions | 86% | |
| Regemat 3D | 86% | |
| Brinter | 84% |
TissueLabs Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
TissueLabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT Alumni Angels | Pre Seed |
| Cietec | Seed |
| Mergus Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 100% MoM, reaching 2.8K.
- Nov 8, 2025
Monthly visitors grew 220% MoM, reaching 5.3K.
TissueLabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TissueLabs's valuation, stock price, and market status.
Is TissueLabs a public or private company?
TissueLabs is a private company.
What is the current stock price of TissueLabs?
TissueLabs is a private company, so its shares have no public market price. Caplight tracks TissueLabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TissueLabs worth (valuation)?
Valuation information for TissueLabs is not publicly available.
Can I buy TissueLabs stock?
TissueLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TissueLabs's last funding round?
TissueLabs's most recent funding round was Pre Seed on March 22, 2024.
Who are the main investors in TissueLabs?
Key investors in TissueLabs include Mergus Ventures.
Will TissueLabs IPO soon?
No public IPO plans have been announced for TissueLabs.
How can I track TissueLabs secondary market activity?
Caplight tracks bids, offers, and trades in TissueLabs's shares on secondary markets.